07.25.13
BIT Group has combined its two California facilities—San Diego-based BIT MedTech and Irvine-based Source Scientific LLC)—to form BIT USA Inc. The restructure will be official in October, and was orchestrated for BIT to better serve its growing U.S. market, according to company officials.
Following a five-year transition of ownership, Source Scientific became a wholly owned BIT Group company in January this year. BIT MedTech (formerly California MedTech) was acquired by BIT Group in August 2011. The new executive team of BIT USA will be led by BIT Group CEO Marius Balger who is currently responsible for BIT Group worldwide. Under the new structure, Balger also will serve as CEO of BIT USA.
“The United States is an extremely important market for BIT Group,” said Balger. “In addition to creating BIT USA Inc.—which will capitalize on economies of scale and offer more customized services to our U.S. customers—we are restructuring our management so as to better focus on our U.S. growth. With a broader presence in the United States, we can offer U.S. customers many BIT Group synergies, such as BIT platform solutions to accelerate products’ time to market or a skilled global R&D team to assist with localized projects.”
Other members of the BIT Group executive team include Gotthard von Falkenhausen as global chief financial officer and Global Chief Operating Officer Thomas Eck, who, in addition to his executive tasks in Schwalbach, Germany, will oversee BIT Group’s business operations worldwide.
BIT Group provides contract product development, manufacturing and after-sales service for life science research, medical and in-vitro diagnostic instrumentation.
Following a five-year transition of ownership, Source Scientific became a wholly owned BIT Group company in January this year. BIT MedTech (formerly California MedTech) was acquired by BIT Group in August 2011. The new executive team of BIT USA will be led by BIT Group CEO Marius Balger who is currently responsible for BIT Group worldwide. Under the new structure, Balger also will serve as CEO of BIT USA.
“The United States is an extremely important market for BIT Group,” said Balger. “In addition to creating BIT USA Inc.—which will capitalize on economies of scale and offer more customized services to our U.S. customers—we are restructuring our management so as to better focus on our U.S. growth. With a broader presence in the United States, we can offer U.S. customers many BIT Group synergies, such as BIT platform solutions to accelerate products’ time to market or a skilled global R&D team to assist with localized projects.”
Other members of the BIT Group executive team include Gotthard von Falkenhausen as global chief financial officer and Global Chief Operating Officer Thomas Eck, who, in addition to his executive tasks in Schwalbach, Germany, will oversee BIT Group’s business operations worldwide.
BIT Group provides contract product development, manufacturing and after-sales service for life science research, medical and in-vitro diagnostic instrumentation.